Tuesday, April 30, 2019

Glenmark Pharma launches anti-diabetes drug Remogliflozin in India


via Markets-Economic Times vilayatimall.com Find Latest Coupons & Offers For Online Shopping Sites. Glenmark said it will commercialise Remogliflozin in India under the brand names 'Remo' and 'Remozen'.

No comments:

Post a Comment